Long-term oncological and functional follow-up in low dose rate brachytherapy (LDR-BT) for prostate cancer: results from the prospective nation-wide Swiss Registry

Uro-Oncology

Robust Health Utility Assessment Among Long-term Survivors of Prostate Cancer: Results from the Cancer of the Prostate Strategic Urologic Research Endeavor Registry

Eur Urol.

Jeong CW, Cowan JE, Broering JM, Ten Ham RMT, Wilson LS, Carroll PR, Cooperberg MR

doi: 10.1016/j.eururo.2019.07.012.

Uro-Oncology

Hemi-Ablative Low-Dose-Rate Prostate Brachytherapy for Unilateral Localised Prostate Cancer

BJU Int.

Langley S, Uribe J, Uribe-Lewis S, Franklin A, Perna C, Horton A, Cunningham M, Higgins D, Deering C, Khaksar S, Laing R

doi: 10.1111/bju.14948.

Uro-Oncology

Early-Medium-Term Outcomes of Primary Focal Cryotherapy to Treat Nonmetastatic Clinically Significant Prostate Cancer from a Prospective Multicentre Registry

Eur Urol.

Shah TT, Peters M, Eldred-Evans D, Miah S, Yap T, Faure-Walker NA, Hosking-Jervis F, Thomas B, Dudderidge T, Hindley RG, McCracken S, Greene D, Nigam R, Valerio M, Minhas S, Winkler M, Arya M, Ahmed HU

doi: 10.1016/j.eururo.

Erectile and Sexual Functions and DysfunctionsUrinary IncontinenceUro-Oncology

Long-term quality of life after definitive treatment for prostate cancer: patient-reported outcomes in the second posttreatment decade

Cancer Med.

Jang JW, Drumm MR, Efstathiou JA, Paly JJ, Niemierko A, Ancukiewicz M, Talcott JA, Clark JA, Zietman AL

doi: 10.1002/cam4.1103.

Uro-Oncology

Long-term outcomes of two ablation techniques for treatment of radio-recurrent prostate cancer

Prostate Cancer Prostatic Dis.

Nair SM, Peters M, Kurver P, Lavi A, Verhoeff JJC, van der Voort van Zyp JRN, van Son MJ, Chin JL

doi: 10.1038/s41391-020-00265-5.

Erectile and Sexual Functions and DysfunctionsLower Urinary Tract Symptoms

Long-term evaluation of urinary, sexual, and quality of life outcomes after brachytherapy for penile carcinoma

Brachytherapy.

Gambachidze D, Lebacle C, Maroun P, Escande A, Bossi A, Blanchard P, Deutsch E, Haie-Meder C, Chargari C

doi: 10.1016/j.brachy.2017.09.006.

Uro-Oncology

Combined high dose rate brachytherapy and external beam radiotherapy for clinically localised prostate cancer

Radiother Oncol.

Strouthos I, Chatzikonstantinou G, Zamboglou N, Milickovic N, Papaioannou S, Bon D, Zamboglou C, Rödel C, Baltas D, Tselis N

doi: 10.1016/j.radonc.2018.04.031.

Uro-Oncology

Association between dihydrotestosterone and long-term risk for prostate cancer mortality: A prospective cohort study

Prostate.

Lundgren PO, Kjellman A, Norming U, Gustafsson O

doi: 10.1002/pros.23991.

Erectile and Sexual Functions and DysfunctionsUro-Oncology

Evaluation of functional outcomes following a second focal-HIFU in men with primary localised, non-metastatic prostate cancer; Results from the High Intensity Focused Ultrasound Evaluation and Assessment of Treatment (HEAT) Registry

BJU Int.

Lovegrove CE, Peters M, Guillaumier S, Arya M, Afzal N, Dudderidge T, Hosking-Jervis F, Hindley RJ, Lewi H, McCartan N, Moore CM, Nigam R, Ogden C, Persad R, Virdi J, Winkler M, Emberton M, Ahmed HU, Shah TT, Minhas S

doi: 10.1111/bju.15004.

Related content

Robust Health Utility Assessment Among Long-term Survivors of Prostate Cancer: Results from the Cancer of the Prostate Strategic Urologic Research Endeavor Registry

Hemi-Ablative Low-Dose-Rate Prostate Brachytherapy for Unilateral Localised Prostate Cancer

Early-Medium-Term Outcomes of Primary Focal Cryotherapy to Treat Nonmetastatic Clinically Significant Prostate Cancer from a Prospective Multicentre Registry

Long-term quality of life after definitive treatment for prostate cancer: patient-reported outcomes in the second posttreatment decade

Long-term outcomes of two ablation techniques for treatment of radio-recurrent prostate cancer

Long-term evaluation of urinary, sexual, and quality of life outcomes after brachytherapy for penile carcinoma

Combined high dose rate brachytherapy and external beam radiotherapy for clinically localised prostate cancer

Association between dihydrotestosterone and long-term risk for prostate cancer mortality: A prospective cohort study

Evaluation of functional outcomes following a second focal-HIFU in men with primary localised, non-metastatic prostate cancer; Results from the High Intensity Focused Ultrasound Evaluation and Assessment of Treatment (HEAT) Registry